Accès ouvert
2025
article
OpenAlex
A. L. Hepburn
Abstract Introduction Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) characterised by skin rash and muscle weakness, and can be linked with interstitial lung disease (ILD). A severe, often amyopathic subtype is associated with the presence of anti-MDA5 antibodies and is linked …
gb
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Christian Robinson, A. L. Hepburn, Robin Turner, Amir Zarrabi
BACKGROUND: To assess the feasibility of a novel intra-operative void scoring technique. To determine if intra-operative void score (VS) could act as a marker for post-operative success following TURP. METHODS: Fifteen patients undergoing TURP were included in this single-centre feasibility study. All …
nz
(code pays fourni par la source)
Accès ouvert
2018
review
OpenAlex
Shawn DP Ellis, Sam T. Kelly, Jonathan Shurlock, A. L. Hepburn
BACKGROUND: Fibromyalgia is a debilitating condition, characterized by extensive muscular pain and fatigue. Vitamin D is essential for overall health, with ubiquitous involvement in various inflammatory and pain pathways. Little is known about its role in fibromyalgia. We performed a systematic literature …
gb
(code pays fourni par la source)
2018
article
OpenAlex
A. L. Hepburn, Nicola Pearson, Gail Darlington, Mike D Chard et autres
Background: Recent UK epidemiological research suggests a hazard ratio of 1.5 for diabetes in RA patients on prednisolone ≥5mg or daily. National guidelines produced by NICE, ARMA and BSR set clear standards for screening for diabetes and other cardiovascular risk factors in …
gb
(code pays fourni par la source)
2015
article
OpenAlex
Todd Leckie, Dominic Nee, A. L. Hepburn
Koperdanova and Cullis provide a concise and pragmatic approach to interpreting serum ferritin levels, which are commonly raised in a range of acute and chronic diseases.1 We would like to mention adult onset Still’s disease—a …
gb
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Joseph Villiers, Munther A. Khamashta, A. L. Hepburn
Antiphospholipid syndrome (APS) is characterised by recurrent arterial and/or venous thromboses and recurrent late miscarriages in the presence of antiphospholipid antibodies, and can be a hugely debilitating disorder. While the commonest thrombotic manifestations of this condition such as deep vein thrombosis and …
gb
(code pays fourni par la source)
2013
conference-abstract
OpenAlex
L. Yalakki Jagadeesh, A. L. Hepburn, Rod Hughes, Brian P. Bourke et autres
gb
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Joseph Villiers, David W. Clark, Tony Jeswani, Scott P. Webster et autres
Osteoporosis is responsible for a significant burden both individually and socially, but is readily treated with antiresorptive agents and mineral supplementation. However, long-term usage of these agents, notably bisphosphonates, is rarely associated with atypical fractures. Denosumab is a monoclonal antibody that reduces …
gb
(code pays fourni par la source)
Accès ouvert
2012
article
OpenAlex
Anuttara Panchali Kumarasinghe, A. L. Hepburn, William J. Reuther, C.A. Pratt
Spontaneous glossodynia is uncommon and glossodynia progressing to necrosis is especially rare. Although the commonest cause of lingual necrosis is giant cell arteritis, only a few cases of a new diagnosis of giant cell arteritis, clinically presenting with isolated lingual necrosis, have …
gb, us
(code pays fourni par la source)
2012
article
OpenAlex
A. L. Hepburn
Clark and colleagues do not cite large vessel vasculitis as an important and readily treatable cause of a discrepancy in blood pressure recordings between limbs.1 For example, Takayasu’s arteritis is a rare granulomatous large vessel vasculitis and a …
gb
(code pays fourni par la source)
2011
article
OpenAlex
Svetlana I. Nihtyanova, V. Ong, C Black, CP Denton et autres
Background: We have previously compared outcome in two groups of systemic sclerosis (SSc) patients with disease onset a decade apart and we reported data on 5 year survival and cumulative incidence of organ disease in a contemporary SSc cohort. The present study …
gb
(code pays fourni par la source)
2011
article
OpenAlex
A. L. Hepburn, Tom Rider, K Jordan
In response to Cayley’s article,1 we would like to clarify some important aspects of the management of gout. In acute gout, we would recommend 0.5 mg of colchicine two to three times daily for three days, in accordance with published guidelines.2 More …
gb
(code pays fourni par la source)